Top Tech Companies (1,066)
Don't see your company?
Create a company profile.jpg)
LinkSquares is the company behind the AI-powered contract management platform of choice for legal teams aiming to move their business forward faster. Contracts are the lifeblood of business and power everything from revenue, obligations, financing activities, and reporting. At LinkSquares, our AI-powered, end-to-end contract management and analytics platform takes the manual, time-consuming, tedious tasks out of the contracting process. With LinkSquares, legal teams have everything they need to write better contracts, get contracts executed quickly, analyze what's in existing contracts, and collaborate better with their team at every step of the way. LinkSquares differs from other tools on the market with its powerful AI insights, speed to tangible results through flexible automation, and ability to centralize everything for better visibility and collaboration. Our customers include VMware, Fitbit, Igloo, Pegasystems, Ionis Pharmaceuticals, and Twilio. LinkSquares was founded in 2015 and is headquartered in Boston, MA.
Suited Connector is a one-of-a-kind data solutions and marketing technology (MarTech) platform that fuels new customer growth and extends customer retention at scale across all consumer verticals including yet not limited to financial services, home services, and insurance. MarTech services are in high demand for major brands looking for new (profitable) revenue streams and increasing consumer lifetime value. These services are even more important to the emerging companies looking to gain market share. Suited Connector thrives to improve consumer experiences and establish long-term, happy partnerships. For the everyday consumer looking for fast and easy ways to access information and get connected with service providers to fit their needs, look no further. Some of our key solutions include the following: - Consumer Acquisition and Retargeting - Portfolio Engagement and Retention - Marketing Signals - Consent Management - Data (List) and Content Management - Marketing Automation - Customer Relationship Management - Web Services Let us know how we can help you.
GrapevineAI delivers whitelisted social campaigns at scale. We match brands of all sizes with the right creators and turn articles, photos, and videos into ads that are ready to launch on paid social channels.
DMVEdu.org is a trusted online platform that offers state-approved driver's education courses. With a commitment to enhancing road safety, DMVEdu.org provides comprehensive, interactive, and convenient online courses for new drivers, designed to meet the unique requirements of each state.
Convene is a premium hospitality company that designs and operates meeting, event, flexible office, and membership spaces. With a network of 38 locations across nine cities in the U.S. and UK, Convene thoughtfully combines beautiful yet intuitive design, fully-integrated technology services, and a warm and welcoming environment to create a turnkey solution for extraordinary meeting and work experiences. Founded in 2009 with the goal of bringing hospitality and lifestyle into traditional commercial real estate assets, Convene partners with the industry’s top landlords to deliver increased value to their assets and premium experiences to their tenants. The company counts Hudson’s Bay Company, Ares, and RXR Realty among its investors and has been named one of America’s 100 Most Promising Companies by Forbes and a Best Workplace by Inc. magazine, Fortune magazine, and Built In. Learn more at https://convene.com/ With the acquisition of etc.venues in 2023, Convene is now the largest provider of premium meeting and event venues in the U.S. and UK.
Caris Life Sciences was founded in 2008 with a simple but powerful purpose – to help improve the lives of as many people as possible. With transformative technologies informed by massive amounts of big data, we are revolutionizing healthcare to provide physicians and patients with the highest quality information about their disease – from detecting it early and determining how best to treat it, to developing the next wave of novel therapies.
